# Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGFβ1

**Authors:** Meredith L Sosulski, Rafael Gongora, Svitlana Danchuk, Chunmin Dong, Fayong Luo, Cecilia G Sanchez

PMC · DOI: 10.1111/acel.12357 · Aging Cell · 2015-06-09

## TL;DR

This study shows that aging reduces autophagy and mitophagy in the lungs, contributing to pulmonary fibrosis, and suggests that improving these processes could help treat age-related fibrotic diseases.

## Contribution

The study identifies age-related defects in autophagy and mitophagy as key contributors to pulmonary fibrosis and highlights TGFβ1's role in this process.

## Key findings

- Older mice show reduced autophagy and elevated oxidized proteins after lung injury.
- TGFβ1-induced FMD is associated with reduced autophagy flux and mitochondrial dysfunction.
- PINK1 expression is reduced in fibrotic lung tissue and IPF patient biopsies.

## Abstract

Aging constitutes a significant risk factor for fibrosis, and idiopathic pulmonary fibrosis (IPF) is characteristically associated with advancing age. We propose that age-dependent defects in the quality of protein and cellular organelle catabolism may be causally related to pulmonary fibrosis. Our research found that autophagy diminished with corresponding elevated levels of oxidized proteins and lipofuscin in response to lung injury in old mice and middle-aged mice compared to younger animals. More importantly, older mice expose to lung injury are characterized by deficient autophagic response and reduced selective targeting of mitochondria for autophagy (mitophagy). Fibroblast to myofibroblast differentiation (FMD) is an important feature of pulmonary fibrosis in which the profibrotic cytokine TGFβ1 plays a pivotal role. Promotion of autophagy is necessary and sufficient to maintain normal lung fibroblasts’ fate. On the contrary, FMD mediated by TGFβ1 is characterized by reduced autophagy flux, altered mitophagy, and defects in mitochondrial function. In accord with these findings, PINK1 expression appeared to be reduced in fibrotic lung tissue from bleomycin and a TGFβ1-adenoviral model of lung fibrosis. PINK1 expression is also reduced in the aging murine lung and biopsies from IPF patients compared to controls. Furthermore, deficient PINK1 promotes a profibrotic environment. Collectively, this study indicates that an age-related decline in autophagy and mitophagy responses to lung injury may contribute to the promotion and/or perpetuation of pulmonary fibrosis. We propose that promotion of autophagy and mitochondrial quality control may offer an intervention against age-related fibrotic diseases.

## Linked entities

- **Genes:** TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], PINK1 (PTEN induced kinase 1) [NCBI Gene 65018]
- **Diseases:** pulmonary fibrosis (MONDO:0002771), idiopathic pulmonary fibrosis (MONDO:0800029), IPF (MONDO:0800504)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Mul1 (mitochondrial ubiquitin ligase activator of NFKB 1) [NCBI Gene 68350] {aka 0610009K11Rik, Gide, Tnrip-1}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, Mtv13 (mammary tumor virus locus 13) [NCBI Gene 111415] {aka Mls, Mls-2, Mls2, Mtv-13}, Ccn2 (cellular communication network factor 2) [NCBI Gene 14219] {aka Ctgf, Fisp12, Hcs24, fisp-12}, Atg5 (autophagy related 5) [NCBI Gene 11793] {aka 2010107M05Rik, 3110067M24Rik, Apg5l, Atg5l, Paddy}, Map1lc3b (microtubule-associated protein 1 light chain 3 beta) [NCBI Gene 67443] {aka 1010001C15Rik, Atg8, LC3b, MAP1A/MAP1B, Map1lc3}, Pink1 (PTEN induced putative kinase 1) [NCBI Gene 68943] {aka 1190006F07Rik, BRPK, mFLJ00387}, Pten (phosphatase and tensin homolog) [NCBI Gene 19211] {aka 2310035O07Rik, A130070J02Rik, B430203M17Rik, MMAC1, PTENbeta, TEP1}, SQSTM1 (sequestosome 1) [NCBI Gene 8878] {aka A170, DMRV, EBIAP, FTDALS3, NADGP, OSIL}, PINK1 (PTEN induced kinase 1) [NCBI Gene 65018] {aka BRPK, PARK6}, SERPINH1 (serpin family H member 1) [NCBI Gene 871] {aka AsTP3, CBP1, CBP2, HSP47, OI10, PIG14}, Tat (tyrosine aminotransferase) [NCBI Gene 234724], Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, MAP1LC3B (microtubule associated protein 1 light chain 3 beta) [NCBI Gene 81631] {aka ATG8F, LC3B, MAP1A/1BLC3, MAP1LC3B-a}, Atg7 (autophagy related 7) [NCBI Gene 74244] {aka 1810013K23Rik, Agp7, Apg7l, Atg7l, Gm21553}, Serpine1 (serine (or cysteine) peptidase inhibitor, clade E, member 1) [NCBI Gene 18787] {aka PAI-1, PAI1, Planh1}, Map1lc3a (microtubule-associated protein 1 light chain 3 alpha) [NCBI Gene 66734] {aka 1010001H21Rik, 4922501H04Rik, LC3, LC3a}, Tomm20 (translocase of outer mitochondrial membrane 20) [NCBI Gene 67952] {aka 1810060K07Rik, Gm19268, MAS20, MOM19, TOM20, mKIAA0016}, Becn1 (beclin 1, autophagy related) [NCBI Gene 56208] {aka Atg6}, Serpinh1 (serine (or cysteine) peptidase inhibitor, clade H, member 1) [NCBI Gene 12406] {aka BERF-1, Cbp1, Cbp2, Hsp47, J6, Serpinh2}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, Map3k10 (mitogen-activated protein kinase kinase kinase 10) [NCBI Gene 269881] {aka MST, Mlk2}, Bnip3l (BCL2/adenovirus E1B interacting protein 3-like) [NCBI Gene 12177] {aka D14Ertd719e, Nip3L, Nix}
- **Diseases:** age-related diseases (MESH:D010024), fibrotic diseases (MESH:D004194), IPF (MESH:D054990), Scleroderma (MESH:D012595), emphysema (MESH:D004646), fibrotic lesion (MESH:D009059), inflammation (MESH:D007249), lipofuscin (MESH:D009472), NHLFs (MESH:D008171), pulmonary fibrosis (MESH:D011658), FMD (MESH:D012734), lung injury (MESH:D055370), fibrosis (MESH:D005355), mitochondrial dysfunction (MESH:D028361), interstitial and intra-alveolar pneumonia (MESH:D017563)
- **Chemicals:** DAPI (MESH:C007293), Resveratrol (MESH:D000077185), SBB (MESH:C016118), Rapamycin (MESH:D020123), chloroquine (MESH:D002738), DCFH-DA (MESH:C029569), ROS (MESH:D017382), hematoxylin (MESH:D006416), ethanol (MESH:D000431), lipofuscin (MESH:D008062), CQ (MESH:C048021), EDTA (MESH:D004492), Bleo (MESH:D001761), DCF (MESH:D015649), FBM (-), LiCl (MESH:D018021), PBS (MESH:D007854), 2,7-dichlorodihydrofluorescein diacetate (MESH:C110400),  (MESH:D053773)
- **Species:** C. elegans [taxon 328850], Mus musculus (house mouse, species) [taxon 10090], fungal sp. M-D (species) [taxon 1074441], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Homo sapiens (human, species) [taxon 9606], Adenoviridae (family) [taxon 10508]
- **Mutations:** G/C915, serine/threonine

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4568965/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4568965/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC4568965/full.md

---
Source: https://tomesphere.com/paper/PMC4568965